| CAR T cells administered in combination with lymphodepletion and PD-1 inhibition to patients with neuroblastoma A Heczey, CU Louis, B Savoldo, O Dakhova, A Durett, B Grilley, H Liu, ... Molecular therapy 25 (9), 2214-2224, 2017 | 475 | 2017 |
| A T-cell–directed chimeric antigen receptor for the selective treatment of T-cell malignancies M Mamonkin, RH Rouce, H Tashiro, MK Brenner Blood, The Journal of the American Society of Hematology 126 (8), 983-992, 2015 | 322 | 2015 |
| Constitutive signaling from an engineered IL7 receptor promotes durable tumor elimination by tumor-redirected T cells T Shum, B Omer, H Tashiro, RL Kruse, DL Wagner, K Parikh, Z Yi, ... Cancer discovery 7 (11), 1238-1247, 2017 | 249 | 2017 |
| Immunotherapy against cancer-related viruses H Tashiro, MK Brenner Cell research 27 (1), 59-73, 2017 | 142 | 2017 |
| Treatment of acute myeloid leukemia with T cells expressing chimeric antigen receptors directed to C-type lectin-like molecule 1 H Tashiro, T Sauer, T Shum, K Parikh, M Mamonkin, B Omer, RH Rouce, ... Molecular Therapy 25 (9), 2202-2213, 2017 | 136 | 2017 |
| CD7 CAR T cells for the therapy of acute myeloid leukemia D Gomes-Silva, E Atilla, PA Atilla, F Mo, H Tashiro, M Srinivasan, P Lulla, ... Molecular Therapy 27 (1), 272-280, 2019 | 125 | 2019 |
| Vaccination targeting native receptors to enhance the function and proliferation of chimeric antigen receptor (CAR)-modified T cells M Tanaka, H Tashiro, B Omer, N Lapteva, J Ando, M Ngo, B Mehta, ... Clinical Cancer Research 23 (14), 3499-3509, 2017 | 87 | 2017 |
| HBsAg-redirected T cells exhibit antiviral activity in HBV-infected human liver chimeric mice RL Kruse, T Shum, H Tashiro, M Barzi, Z Yi, C Whitten-Bauer, X Legras, ... Cytotherapy 20 (5), 697-705, 2018 | 82 | 2018 |
| Comprehensive approach for identifying the T cell subset origin of CD3 and CD28 antibody–activated chimeric antigen receptor–modified T cells M Schmueck-Henneresse, B Omer, T Shum, H Tashiro, M Mamonkin, ... The Journal of Immunology 199 (1), 348-362, 2017 | 52 | 2017 |
| Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia PA Atilla, MK McKenna, H Tashiro, M Srinivasan, F Mo, N Watanabe, ... Journal for immunotherapy of cancer 8 (2), 2020 | 41 | 2020 |
| Mutated GM‐CSF‐based CAR‐T cells targeting CD116/CD131 complexes exhibit enhanced anti‐tumor effects against acute myeloid leukaemia A Hasegawa, S Saito, S Narimatsu, S Nakano, M Nagai, H Ohnota, ... Clinical & Translational Immunology 10 (5), e1282, 2021 | 25 | 2021 |
| Molecular analysis of chronic eosinophilic leukemia with t (4; 10) showing good response to imatinib mesylate H Tashiro, R Shirasaki, M Noguchi, M Gotoh, K Kawasugi, N Shirafuji International journal of hematology 83, 433-438, 2006 | 19 | 2006 |
| Chimeric antigen receptor signaling domains differentially regulate proliferation and native T cell receptor function in virus-specific T cells B Omer, PA Castillo, H Tashiro, T Shum, MTA Huynh, M Cardenas, ... Frontiers in medicine 5, 343, 2018 | 17 | 2018 |
| Hyperuricemia in hematologic malignancies is caused by an insufficient urinary excretion Y Oka, H Tashiro, R Sirasaki, T Yamamoto, N Akiyama, K Kawasugi, ... Nucleosides, Nucleotides and Nucleic Acids 33 (4-6), 434-438, 2014 | 16 | 2014 |
| Effect of related donor availability on outcome of AML in the context of related and unrelated hematopoietic cell transplantation M Yanada, S Kurosawa, T Yamaguchi, N Uchida, S Miyawaki, ... Bone marrow transplantation 48 (3), 390-395, 2013 | 16 | 2013 |
| The prognostic impact of FLT3-ITD, NPM1 and CEBPa in cytogenetically intermediate-risk AML after first relapse S Kurosawa, H Yamaguchi, T Yamaguchi, K Fukunaga, S Yui, ... International journal of hematology 112, 200-209, 2020 | 11 | 2020 |
| FLT3 internal tandem duplication is associated with a high relapse rate and central nervous system involvement in acute promyelocytic leukemia cases: single institutional analysis. H Tashiro, R Shirasaki, Y Oka, T Sugao, M Mizutani-Noguchi, ... European journal of haematology 86 (3), 2011 | 11 | 2011 |
| Mutational analysis of DNMT3A improves the prognostic stratification of patients with acute myeloid leukemia S Wakita, A Marumo, K Morita, S Kako, T Toya, Y Najima, N Doki, J Kanda, ... Cancer science 114 (4), 1297-1308, 2023 | 9 | 2023 |
| CD7 CAR for the treatment of acute myeloid and lymphoid leukemia D Silva, H Tashiro, M Srinivasan, MK Brenner, M Mamonkin Blood, The Journal of the American Society of Hematology 128 (22), 4555-4555, 2016 | 9 | 2016 |
| Colonic EBV‐Associated Lymphoproliferative Disorder in a Patient Treated with Rabbit Antithymocyte Globulin for Aplastic Anemia H Sugimoto-Sekiguchi, H Tashiro, R Shirasaki, T Arai, T Yamamoto, ... Case Reports in Gastrointestinal Medicine 2012 (1), 395801, 2012 | 8 | 2012 |
